Loading...
OTCMCHHMF
Market cap1.18bUSD
, Last price  
0.00USD
Name

Chemometec A/S

Chart & Performance

D1W1MN
OTCM:CHHMF chart
P/E
P/S
EPS
7.83
Div Yield, %
%
Shrs. gr., 5y
2.27%
Rev. gr., 5y
18.37%
Revenues
408m
-8.22%
11,446,00014,604,00022,310,00044,823,00032,052,00032,608,00037,231,00039,201,00041,396,00045,229,00061,239,00085,232,00090,329,000112,687,000175,513,000214,101,000281,127,000428,391,000444,401,000407,870,000
Net income
136m
-23.72%
-2,355,0004,094,000843,00013,230,0004,598,000-3,687,000108,000-9,868,000346,0001,150,0007,948,00010,483,0007,486,00018,215,00041,845,00059,163,00088,354,000159,469,000178,667,000136,284,000
CFO
129m
-16.31%
-283,000486,000-812,0001,341,00015,333,0006,709,0007,794,0008,865,0007,819,0005,667,00013,394,00017,200,0009,757,00025,436,00058,310,00072,016,000107,901,000176,860,000154,146,000129,002,000
Earnings
Feb 05, 2025

Profile

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal production; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. It also provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. The company was incorporated in 1997 and is headquartered in Allerød, Denmark.
IPO date
Dec 18, 2006
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
407,870
-8.22%
444,401
3.74%
428,391
52.38%
Cost of revenue
48,668
55,471
91,769
Unusual Expense (Income)
NOPBT
359,202
388,930
336,622
NOPBT Margin
88.07%
87.52%
78.58%
Operating Taxes
40,302
51,693
43,751
Tax Rate
11.22%
13.29%
13.00%
NOPAT
318,900
337,237
292,871
Net income
136,284
-23.72%
178,667
12.04%
159,469
80.49%
Dividends
(104,415)
(69,610)
Dividend yield
1.97%
0.53%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,181
3,517
1,934
Long-term debt
3,798
9,792
10,629
Deferred revenue
(18,019)
(14,930)
Other long-term liabilities
3,400
2,100
1,830
Net debt
(289,167)
(465,928)
(338,946)
Cash flow
Cash from operating activities
129,002
154,146
176,860
CAPEX
(20,947)
(40,816)
(55,916)
Cash from investing activities
(43,494)
(40,831)
(56,046)
Cash from financing activities
(105,715)
(2,925)
(69,012)
FCF
345,232
183,414
338,488
Balance
Cash
296,146
316,571
209,025
Long term investments
162,666
142,484
Excess cash
275,752
457,017
330,089
Stockholders' equity
565,294
428,627
714,384
Invested Capital
297,118
145,653
(34,200)
ROIC
144.05%
605.17%
3,502.71%
ROCE
61.79%
65.66%
108.30%
EV
Common stock shares outstanding
17,402
17,402
17,402
Price
304.60
-34.64%
466.00
-38.44%
757.00
-10.25%
Market cap
5,300,795
-34.64%
8,109,555
-38.44%
13,173,677
-10.25%
EV
5,011,628
7,643,627
13,191,910
EBITDA
376,413
409,399
356,660
EV/EBITDA
13.31
18.67
36.99
Interest
183
1,088
1,517
Interest/NOPBT
0.05%
0.28%
0.45%